Paraplegia subsequent to administration of tissue plasminogen activator and intravenous heparin following myocardial infarction--a case report

R DePorto; J H Ahn; J G Gianutsos

doi:10.1080/10790268.2000.11753523

Paraplegia subsequent to administration of tissue plasminogen activator and intravenous heparin following myocardial infarction--a case report

J Spinal Cord Med. 2000 Summer;23(2):150-2. doi: 10.1080/10790268.2000.11753523.

Authors

R DePorto¹, J H Ahn, J G Gianutsos

Affiliation

¹ Department of Rehabilitation Medicine, New York University Medical Center, New York, USA.

PMID: 10914357
DOI: 10.1080/10790268.2000.11753523

Abstract

A case involving spinal epidural hematoma following tissue plasminogen activator and intravenous heparin therapy administered after acute myocardial infarction is reported here. The symptoms of spinal epidural hematoma following thrombolytic therapy are outlined and a recommended course of action for arriving at a definitive diagnosis of suspected epidural hematoma is provided.

Publication types

Case Reports

MeSH terms

Aged
Drug Therapy, Combination
Hematoma, Epidural, Cranial / chemically induced*
Hematoma, Epidural, Cranial / diagnosis
Heparin / administration & dosage
Heparin / adverse effects*
Humans
Infusions, Intravenous
Magnetic Resonance Imaging
Male
Myocardial Infarction / drug therapy*
Paraplegia / chemically induced*
Paraplegia / diagnosis
Thrombolytic Therapy*
Tissue Plasminogen Activator / administration & dosage
Tissue Plasminogen Activator / adverse effects*

Substances

Heparin
Tissue Plasminogen Activator